Published in Lab Invest on March 08, 2010
Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2. Proc Natl Acad Sci U S A (2013) 2.26
Consistent in-frame internal tandem duplications of BCOR characterize clear cell sarcoma of the kidney. Nat Genet (2015) 1.84
SWI/SNF chromatin-remodeling factors: multiscale analyses and diverse functions. J Biol Chem (2012) 1.24
Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children's Oncology Group Study. Neoplasia (2012) 1.19
Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth. Cancer Genet (2014) 1.10
Molecular pathways: SWI/SNF (BAF) complexes are frequently mutated in cancer--mechanisms and potential therapeutic insights. Clin Cancer Res (2013) 1.07
Aberrant BAF57 signaling facilitates prometastatic phenotypes. Clin Cancer Res (2013) 0.94
Genome-Wide Profiles of Extra-cranial Malignant Rhabdoid Tumors Reveal Heterogeneity and Dysregulated Developmental Pathways. Cancer Cell (2016) 0.89
Epigenetic inactivation of the tumor suppressor BIN1 drives proliferation of SNF5-deficient tumors. Cell Cycle (2012) 0.88
Pediatric rhabdoid tumors of kidney and brain show many differences in gene expression but share dysregulation of cell cycle and epigenetic effector genes. Pediatr Blood Cancer (2013) 0.77
Congenital anomalies and rhabdoid tumor associated with 22q11 germline deletion and somatic inactivation of the SMARCB1 tumor suppressor. Genes Chromosomes Cancer (2011) 0.77
Study of the gene expression and microRNA expression profiles of malignant rhabdoid tumors originated in the brain (AT/RT) and in the kidney (RTK). Childs Nerv Syst (2013) 0.77
CD146 is a novel marker for highly tumorigenic cells and a potential therapeutic target in malignant rhabdoid tumor. Oncogene (2016) 0.76
The occurrence of intracranial rhabdoid tumours in mice depends on temporal control of Smarcb1 inactivation. Nat Commun (2016) 0.76
International pediatric liver cancer pathological classification: current trend. Int J Clin Oncol (2013) 0.76
Whole Exome- and mRNA-Sequencing of an AT/RT Case Reveals Few Somatic Mutations and Several Deregulated Signalling Pathways in the Context of SMARCB1 Deficiency. Biomed Res Int (2015) 0.75
Establishment and characterization of MRT cell lines from genetically engineered mouse models and the influence of genetic background on their development. Int J Cancer (2012) 0.75
Imputing Gene Expression to Maximize Platform Compatibility. Bioinformatics (2016) 0.75
Oncogenic roles of SMARCB1/INI1 and its deficient tumors. Cancer Sci (2017) 0.75
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46
Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature (2007) 65.18
Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature (2006) 25.90
Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science (2002) 24.31
PANTHER: a library of protein families and subfamilies indexed by function. Genome Res (2003) 21.64
Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature (2005) 19.56
Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature (2002) 15.36
Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer (2006) 11.48
Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells. Cell Stem Cell (2007) 8.59
MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol Cell (2002) 8.17
Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature (1998) 7.55
Whole-genome mapping of histone H3 Lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells. Cell Stem Cell (2007) 7.05
Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev (2001) 6.36
The SWI/SNF complex--chromatin and cancer. Nat Rev Cancer (2004) 4.59
An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets. Genome Biol (2003) 4.49
The transcriptional program of a human B cell line in response to Myc. Nucleic Acids Res (2001) 4.08
Imprinting along the Kcnq1 domain on mouse chromosome 7 involves repressive histone methylation and recruitment of Polycomb group complexes. Nat Genet (2004) 3.33
Nestin expression--a property of multi-lineage progenitor cells? Cell Mol Life Sci (2004) 3.26
Recent advances in understanding chromatin remodeling by Swi/Snf complexes. Curr Opin Genet Dev (2003) 3.16
Pigment epithelium-derived factor is a niche signal for neural stem cell renewal. Nat Neurosci (2006) 3.12
SOX10 maintains multipotency and inhibits neuronal differentiation of neural crest stem cells. Neuron (2003) 2.98
c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function. Nat Genet (1999) 2.95
Chromatin remodelling factor Mll1 is essential for neurogenesis from postnatal neural stem cells. Nature (2009) 2.87
Repression of cyclin D1: a novel function of MYC. Mol Cell Biol (1994) 2.67
The C-terminal SET domains of ALL-1 and TRITHORAX interact with the INI1 and SNR1 proteins, components of the SWI/SNF complex. Proc Natl Acad Sci U S A (1998) 2.52
Atlas of gene expression in the developing kidney at microanatomic resolution. Dev Cell (2008) 2.44
The c-myc gene is a direct target of mammalian SWI/SNF-related complexes during differentiation-associated cell cycle arrest. Cancer Res (2006) 2.36
Atypical teratoid/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group study. Am J Surg Pathol (1998) 2.32
Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5. Mol Cell Biol (2002) 2.15
SWI/SNF mediates polycomb eviction and epigenetic reprogramming of the INK4b-ARF-INK4a locus. Mol Cell Biol (2008) 2.14
Function of the c-Myc oncoprotein in chromatin remodeling and transcription. Biochim Biophys Acta (2001) 2.02
Histone and DNA methylation defects at Hox genes in mice expressing a SET domain-truncated form of Mll. Proc Natl Acad Sci U S A (2006) 1.98
Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation. Proc Natl Acad Sci U S A (2005) 1.96
DOCK4, a GTPase activator, is disrupted during tumorigenesis. Cell (2003) 1.94
Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1 arrest associated with induction of p16ink4a and activation of RB. Oncogene (2002) 1.81
Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res (2002) 1.81
Snail precedes slug in the genetic cascade required for the specification and migration of the Xenopus neural crest. Development (2003) 1.74
The SWI/SNF chromatin remodeling protein Brg1 is required for vertebrate neurogenesis and mediates transactivation of Ngn and NeuroD. Development (2004) 1.72
Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors. Am J Surg Pathol (2004) 1.69
P16INK4a is required for hSNF5 chromatin remodeler-induced cellular senescence in malignant rhabdoid tumor cells. J Biol Chem (2003) 1.67
The protooncogene c-myc is an essential regulator of neural crest formation in xenopus. Dev Cell (2003) 1.65
Sox proteins and neural crest development. Semin Cell Dev Biol (2005) 1.57
Loss of the hSNF5 gene concomitantly inactivates p21CIP/WAF1 and p16INK4a activity associated with replicative senescence in A204 rhabdoid tumor cells. Cancer Res (2005) 1.54
The role of INI1 and the SWI/SNF complex in the development of rhabdoid tumors: meeting summary from the workshop on childhood atypical teratoid/rhabdoid tumors. Cancer Res (2002) 1.51
Genetic ablation of Cyclin D1 abrogates genesis of rhabdoid tumors resulting from Ini1 loss. Proc Natl Acad Sci U S A (2005) 1.48
Galectin-1 as a potential cancer target. Br J Cancer (2005) 1.45
Rhabdoid tumor of the kidney in the National Wilms' Tumor Study: age at diagnosis as a prognostic factor. J Clin Oncol (2005) 1.45
The basic helix-loop-helix genes Hesr1/Hey1 and Hesr2/Hey2 regulate maintenance of neural precursor cells in the brain. J Biol Chem (2003) 1.41
Phase I study of recombinant human endostatin in patients with advanced solid tumors. J Clin Oncol (2002) 1.41
Receptor-type protein-tyrosine phosphatase-kappa regulates epidermal growth factor receptor function. J Biol Chem (2005) 1.35
Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435. Clin Exp Metastasis (2006) 1.30
Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood. J Neurooncol (1995) 1.25
The SWI/SNF chromatin-remodeling complex subunit SNF5 is essential for hepatocyte differentiation. EMBO J (2005) 1.23
Early steps in neural crest specification. Semin Cell Dev Biol (2005) 1.21
Osteopontin as a molecular prognostic marker for melanoma. Cancer (2008) 1.20
Clear cell sarcoma of the kidney: up-regulation of neural markers with activation of the sonic hedgehog and Akt pathways. Clin Cancer Res (2005) 1.18
Isolation and characterization of murine neural stem/progenitor cells based on Prominin-1 expression. Exp Neurol (2007) 1.15
The ZNF217 oncogene is a candidate organizer of repressive histone modifiers. Epigenetics (2009) 1.14
Role of DNA methylation and histone H3 lysine 27 methylation in tissue-specific imprinting of mouse Grb10. Mol Cell Biol (2006) 1.12
The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumors. Oncogene (2007) 1.10
Endostatin: the logic of antiangiogenic therapy. Drug Resist Updat (2005) 1.07
Snf5 tumor suppressor couples chromatin remodeling, checkpoint control, and chromosomal stability. Cancer Cell (2005) 1.07
Molecular association between beta-catenin degradation complex and Rac guanine exchange factor DOCK4 is essential for Wnt/beta-catenin signaling. Oncogene (2008) 1.07
Xenopus Id3 is required downstream of Myc for the formation of multipotent neural crest progenitor cells. Development (2005) 1.03
The tumor suppressor hSNF5/INI1 modulates cell growth and actin cytoskeleton organization. Cancer Res (2004) 1.03
Expression and characterization of recombinant osteopontin peptides representing matrix metalloproteinase proteolytic fragments. Matrix Biol (2004) 1.03
Targeting cyclin D1, a downstream effector of INI1/hSNF5, in rhabdoid tumors. Oncogene (2006) 1.01
Imprinted CDKN1C is a tumor suppressor in rhabdoid tumor and activated by restoration of SMARCB1 and histone deacetylase inhibitors. PLoS One (2009) 0.99
INI1 induces interferon signaling and spindle checkpoint in rhabdoid tumors. Clin Cancer Res (2007) 0.96
HB-GAM inhibits proliferation and enhances differentiation of neural stem cells. Mol Cell Neurosci (2004) 0.92
Detection of the ETV6-NTRK3 chimeric RNA of infantile fibrosarcoma/cellular congenital mesoblastic nephroma in paraffin-embedded tissue: application to challenging pediatric renal stromal tumors. Mod Pathol (2000) 0.91
Classification of malignant pediatric renal tumors by gene expression. Pediatr Blood Cancer (2006) 0.91
The tumour suppressor hSNF5/INI1 controls the differentiation potential of malignant rhabdoid cells. Eur J Cancer (2006) 0.91
Increased expression of osteopontin gene in atypical teratoid/rhabdoid tumor of the central nervous system. Mod Pathol (2005) 0.87
The role of INI1/hSNF5 in gene regulation and cancer. Biochem Cell Biol (2009) 0.84
Differential expression profiling between atypical teratoid/rhabdoid and medulloblastoma tumor in vitro and in vivo using microarray analysis. Childs Nerv Syst (2009) 0.83
A novel model for an older remodeler: the BAF swap in neurogenesis. Neuron (2007) 0.77
Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med (2002) 21.28
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med (2003) 8.48
Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics (2010) 7.78
Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics (2002) 4.56
POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res (2003) 2.45
Gain of 1q is associated with inferior event-free and overall survival in patients with favorable histology Wilms tumor: a report from the Children's Oncology Group. Cancer (2013) 2.32
Sugar-sweetened beverage, sugar intake of individuals, and their blood pressure: international study of macro/micronutrients and blood pressure. Hypertension (2011) 2.29
Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study. J Clin Oncol (2006) 2.15
Protein profiles associated with survival in lung adenocarcinoma. Proc Natl Acad Sci U S A (2003) 1.86
Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor. Pediatr Blood Cancer (2006) 1.74
Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors. Am J Surg Pathol (2004) 1.69
Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. Clin Cancer Res (2002) 1.67
RANTES expression is a predictor of survival in stage I lung adenocarcinoma. Clin Cancer Res (2002) 1.67
Dietary starch intake of individuals and their blood pressure: the International Study of Macronutrients and Micronutrients and Blood Pressure. J Hypertens (2009) 1.61
Somatic acquisition and signaling of TGFBR1*6A in cancer. JAMA (2005) 1.59
Novel candidate targets of beta-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas. Cancer Res (2003) 1.46
Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study. PLoS One (2012) 1.45
Renal medullary carcinoma: clinical, pathologic, immunohistochemical, and genetic analysis with pathogenetic implications. Urology (2002) 1.44
Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group. Pediatr Blood Cancer (2007) 1.43
Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study. J Clin Oncol (2004) 1.37
High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor. J Clin Oncol (2005) 1.35
Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis. Biol Reprod (2007) 1.34
Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer. Cancer Res (2007) 1.33
Children's Oncology Group's 2013 blueprint for research: renal tumors. Pediatr Blood Cancer (2012) 1.32
Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457--a report from the Children's Oncology Group. J Clin Oncol (2006) 1.30
Management of Wilms' tumour: current practice and future goals. Lancet Oncol (2004) 1.28
Long-term outcomes for infants with very low risk Wilms tumor treated with surgery alone in National Wilms Tumor Study-5. Ann Surg (2010) 1.28
Tgfbr1 haploinsufficiency is a potent modifier of colorectal cancer development. Cancer Res (2009) 1.26
Molecular signatures in skin associated with clinical improvement during mycophenolate treatment in systemic sclerosis. J Invest Dermatol (2013) 1.19
Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children's Oncology Group Study. Neoplasia (2012) 1.19
Clear cell sarcoma of the kidney: up-regulation of neural markers with activation of the sonic hedgehog and Akt pathways. Clin Cancer Res (2005) 1.18
Bilateral Wilms' tumors with progressive or nonresponsive disease. J Pediatr Surg (2006) 1.14
Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy. Ann Surg (2003) 1.14
Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a "new" virus associated with Kawasaki disease. J Infect Dis (2011) 1.12
Characteristics and outcomes of children with the Wilms tumor-Aniridia syndrome: a report from the National Wilms Tumor Study Group. J Clin Oncol (2003) 1.11
Overexpression of oncoprotein 18 correlates with poor differentiation in lung adenocarcinomas. Mol Cell Proteomics (2003) 1.11
hTERT gene amplification and increased mRNA expression in central nervous system embryonal tumors. Am J Pathol (2003) 1.11
RANBP2 and CLTC are involved in ALK rearrangements in inflammatory myofibroblastic tumors. Cancer Genet Cytogenet (2007) 1.10
CITED1 expression in Wilms' tumor and embryonic kidney. Neoplasia (2007) 1.10
Epigenetic differences between Wilms' tumours in white and east-Asian children. Lancet (2004) 1.10
TGFBR1*6A enhances the migration and invasion of MCF-7 breast cancer cells through RhoA activation. Cancer Res (2008) 1.09
Comparative genomic hybridization detects an increased number of chromosomal alterations in large cell/anaplastic medulloblastomas. Brain Pathol (2002) 1.08
Transcriptional diversity during monocyte to macrophage differentiation. Immunol Lett (2008) 1.06
Renal medullary carcinoma and ABL gene amplification. J Urol (2005) 1.05
Bilateral Wilms' tumor with anaplasia: lessons from the National Wilms' Tumor Study. J Pediatr Surg (2006) 1.05
Clinicopathologic findings predictive of relapse in children with stage III favorable-histology Wilms tumor. J Clin Oncol (2013) 1.04
Contribution of resistance-nodulation-division efflux pump operon smeU1-V-W-U2-X to multidrug resistance of Stenotrophomonas maltophilia. Antimicrob Agents Chemother (2011) 1.03
Molecular profiling reveals frequent gain of MYCN and anaplasia-specific loss of 4q and 14q in Wilms tumor. Genes Chromosomes Cancer (2011) 1.01
Primary synovial sarcoma of the kidney diagnosed by molecular detection of SYT-SSX fusion transcripts. J Urol (2002) 1.00
IGF2/H19 imprinting analysis of human germ cell tumors (GCTs) using the methylation-sensitive single-nucleotide primer extension method reflects the origin of GCTs in different stages of primordial germ cell development. Genes Chromosomes Cancer (2005) 1.00
Molecular genetic analysis of central nervous system germ cell tumors with comparative genomic hybridization. Mod Pathol (2006) 0.99
Proteomic analysis of cytokeratin isoforms uncovers association with survival in lung adenocarcinoma. Neoplasia (2002) 0.98
Visual presentation as a welcome alternative to textual presentation of gene annotation information. Adv Exp Med Biol (2010) 0.97
Predicting relapse in favorable histology Wilms tumor using gene expression analysis: a report from the Renal Tumor Committee of the Children's Oncology Group. Clin Cancer Res (2009) 0.96
Methylation-associated silencing of the heat shock protein 47 gene in human neuroblastoma. Cancer Res (2004) 0.96
β-Catenin and K-RAS synergize to form primitive renal epithelial tumors with features of epithelial Wilms' tumors. Am J Pathol (2011) 0.94
Childhood carcinoid tumors: description of a case series in a Brazilian cancer center. Sao Paulo Med J (2006) 0.92
Genetic analysis of mediastinal nonseminomatous germ cell tumors in children and adolescents. Genes Chromosomes Cancer (2002) 0.92
Lymph node involvement in Wilms tumor: results from National Wilms Tumor Studies 4 and 5. J Pediatr Surg (2012) 0.91
Performance characteristics of a reverse transcriptase-polymerase chain reaction assay for the detection of tumor-specific fusion transcripts from archival tissue. Pediatr Dev Pathol (2002) 0.91
Classification of malignant pediatric renal tumors by gene expression. Pediatr Blood Cancer (2006) 0.91
SNAPIN: an endogenous Toll-like receptor ligand in rheumatoid arthritis. Ann Rheum Dis (2012) 0.90
Detection of preoperative wilms tumor rupture with CT: a report from the Children's Oncology Group. Radiology (2012) 0.90
Upregulation of mir-221 and mir-222 in atypical teratoid/rhabdoid tumors: potential therapeutic targets. Childs Nerv Syst (2009) 0.90
Synchronous bilateral Wilm's tumor with complete radiographic response managed without surgical resection: a report from the National Wilm's Tumor Study 4. J Pediatr Surg (2008) 0.89
Genetic and genetic expression analyses of clear cell sarcoma of the kidney. Lab Invest (2003) 0.89
Subsets of very low risk Wilms tumor show distinctive gene expression, histologic, and clinical features. Clin Cancer Res (2009) 0.88
Identification of estrogen-responsive genes involved in breast cancer metastases to the bone. Clin Exp Metastasis (2007) 0.87
Mediators of receptor tyrosine kinase activation in infantile fibrosarcoma: a Children's Oncology Group study. J Pathol (2012) 0.85
Outcomes of patients with revised stage I clear cell sarcoma of kidney treated in National Wilms Tumor Studies 1-5. Int J Radiat Oncol Biol Phys (2012) 0.85
Clinical Outcome and Biological Predictors of Relapse After Nephrectomy Only for Very Low-risk Wilms Tumor: A Report From Children's Oncology Group AREN0532. Ann Surg (2016) 0.85
Activation of Wnt/beta-catenin signaling in distinct histologic subtypes of human germ cell tumors. Pediatr Dev Pathol (2006) 0.85
Anaplastic sarcoma of the kidney: a clinicopathologic study of 20 cases of a new entity with polyphenotypic features. Am J Surg Pathol (2007) 0.84
Metabolomic characterization of laborers exposed to welding fumes. Chem Res Toxicol (2012) 0.84
Integrins α4 and αM, collagen1A1, and matrix metalloproteinase 7 are upregulated in acute Kawasaki disease vasculopathy. Pediatr Res (2012) 0.84
Outcome of patients with Stage II/favorable histology Wilms tumor with and without local tumor spill: a report from the National Wilms Tumor Study Group. Pediatr Blood Cancer (2013) 0.84
Expression of WT-1, Bcl-2, and CD34 by primary renal spindle cell tumors in children. Pediatr Dev Pathol (2004) 0.83
Proteomic analysis of eIF-5A in lung adenocarcinomas. Proteomics (2003) 0.83
Differential gene expression of soluble CD8+ T-cell mediated suppression of HIV replication in three older children. J Med Virol (2011) 0.82
Paracrine-stimulated gene expression profile favors estradiol production in breast tumors. Mol Cell Endocrinol (2006) 0.82
MicroRNA expression profiling for molecular classification of pediatric brain tumors. Pediatr Blood Cancer (2011) 0.81
Protocol for the examination of specimens from patients with Wilms tumor (nephroblastoma) or other renal tumors of childhood. Arch Pathol Lab Med (2003) 0.81
Meta-analysis based variable selection for gene expression data. Biometrics (2014) 0.80
An inducible fusaric acid tripartite efflux pump contributes to the fusaric acid resistance in Stenotrophomonas maltophilia. PLoS One (2012) 0.80
A Parallel Study of mRNA and microRNA Profiling of Peripheral Blood in Young Adult Women. Front Genet (2011) 0.80
Management of adults with Wilms' tumor: recommendations based on international consensus. Expert Rev Anticancer Ther (2011) 0.79
Pilot study of etanercept in patients with refractory juvenile dermatomyositis. Arthritis Care Res (Hoboken) (2014) 0.78